InvestSMART

Little Green Pharma Ltd (ASX:LGP)

ALERT: Price-sensitive ASX Announcement for LGP
Current share price for LGP : $0.076 -0.029 (-27.62%)+
Announcement
Release
17 Jul 2025 9:28AM
Price at Release
$0.105
Full Release
download
Summary
The Quarterly Activities Report and Appendix 4C for Little Green Pharma Ltd (LGP) for the quarter ending 31 March 2024 provides an overview of the company’s operational and financial performance. The report details record quarterly global sales revenue, the company’s strategic focus on the European and Australian medicinal cannabis markets, and significant milestones including new product launches, partnerships, and regulatory achievements. LGP outlines its progress in research and development, patient access, and commercial operations, while also providing financial highlights, cash flow analysis, and commentary on funding and capital management. The company reiterates its commitment to growth, compliance, and shareholder value as it navigates evolving market dynamics.
Key Points
  • Record global quarterly sales revenue achieved, driven by strong performance in European and Australian markets.
  • Continued focus on medicinal cannabis, with new product launches and regulatory approvals advancing market presence.
  • Expansion of distribution agreements and partnerships to increase market access in key regions.
  • Ongoing investment in research and development aimed at product innovation and clinical evidence generation.
  • Progress in patient access initiatives and education to support prescribing healthcare professionals.
  • Detailed financial highlights, including cash flow and funding position, with emphasis on prudent capital management.
  • Commitment to operational efficiency, compliance, and shareholder value amid evolving regulatory environments.
  • Strategic review and adaptation to market opportunities and challenges to drive sustainable growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.